‘LIfe-Changing’ Psychedelic, for When Life Is Ending

Published On Dec 17, 2024, 3:00 AM

The article discusses how patients with serious medical conditions are embracing psychedelic treatments like psilocybin and ketamine for palliative care, especially to manage anxiety and depression associated with terminal illnesses. It highlights a specific case of Barry Blechman, who experienced significant improvement in his mental wellbeing after psilocybin therapy. The demand for these therapies is increasing, particularly in states like Oregon and Colorado, where such treatments can be received legally. Given the growing trend and reported positive outcomes, this emerging market for psychedelic therapies may present notable investment opportunities.